PepGen Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from PepGen Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Steadiness Ratio: Sales grew in 0 of the last 3 years; profit grew in 1 of 3. Less steady than 86% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
-69.3×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 77% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 1/3Sales grew in 0 of the last 3 years; profit grew in 1 of 3.
Less steady than 86% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-25.6×Operating cash was negative last year, while some debt falls due within a year.
Lower than 61% of Healthcare companies in United States.
Cash Cushion Ratio
+70%Cash, after subtracting all debt, equals 70% of its market value (net cash).
Higher than 83% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (10)
PepGen Inc. made a loss over the last year. PepGen Inc. owes $0.15 for every $1 it owns. PepGen Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossPepGen Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
1.56The share price is 1.56 times PepGen Inc.'s book value per share, lower than 66% of Healthcare companies in United States.
Market cap
$187 MThe total market value of all of PepGen Inc.'s shares at today's price (share price × number of shares), smaller than 59% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$120 MWhat PepGen Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$1.73Net worth divided by the number of shares. The share price of $2.70 is 1.6 times this, which is the P/B above.
Return on equity (ROE)
-75.5%PepGen Inc. lost 75.5% of its shareholders' money over the last year, lower than 63% of Healthcare companies in United States.
Owes vs Owns
0.15×PepGen Inc. owes $0.15 for every $1 it owns (low), lower than 79% of Healthcare companies in United States.
Dividend yield
NonePepGen Inc. does not currently pay a dividend.
Profit growth
LossPepGen Inc. made a loss in each of the last two years.
Cash vs debt
Net cashPepGen Inc. held $131 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For PepGen Inc.: $187 M ÷ $120 M (30 Jun 2026) = 1.6.
What is PepGen Inc.'s return on equity?
PepGen Inc. lost 75.5% of its shareholders' money over the last year, lower than 63% of Healthcare companies in United States.
How much does PepGen Inc. owe compared with what it owns?
PepGen Inc. owes $0.15 for every $1 it owns (low), lower than 79% of Healthcare companies in United States.
Does PepGen Inc. pay a dividend?
No. PepGen Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.